FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.

Int J Biol Sci

Department of Geriatric Gastroenterology, Neuroendocrine Tumor Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Institute of Neuroendocrine Tumor, Nanjing Medical University, Nanjing, China.

Published: July 2023

Lipid metabolism plays an important role in the occurrence and development of cancer, in particular, digestive system tumors such as colon cancer. Here, we investigated the role of the fatty acid-binding protein 5 () in colorectal cancer (CRC). We observed marked down-regulation of in CRC. Data from functional assays revealed inhibitory effects of on cell proliferation, colony formation, migration, invasion as well as tumor growth . In terms of mechanistic insights, interacted with fatty acid synthase () and activated the ubiquitin proteasome pathway, leading to a decrease in expression and lipid accumulation, moreover, suppressing signaling and facilitating cell autophagy. Orlistat, a inhibitor, exerted anti-cancer effects both and . Furthermore, the upstream RNA demethylase positively regulated expression via an mA-independent mechanism. Overall, our collective findings offer valuable insights into the critical role of the // axis in tumor progression and uncover a potential mechanism linking lipid metabolism to development of CRC, providing novel therapeutic targets for future interventions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321282PMC
http://dx.doi.org/10.7150/ijbs.85285DOI Listing

Publication Analysis

Top Keywords

colorectal cancer
8
expression lipid
8
lipid metabolism
8
fabp5 suppresses
4
suppresses colorectal
4
cancer
4
cancer progression
4
progression mtor-mediated
4
mtor-mediated autophagy
4
autophagy decreasing
4

Similar Publications

Importance: Research indicates that social drivers of health are associated with cancer screening adherence, although the exact magnitude of these associations remains unclear.

Objective: To investigate the associations between individual-level social risks and nonadherence to guideline-recommended cancer screenings.

Design, Setting, And Participants: This cross-sectional study used 2022 Behavioral Risk Factor Surveillance System data from 39 US states and Washington, DC.

View Article and Find Full Text PDF

Impact of adjuvant chemotherapy on survival in ypT0-2 N0 rectal cancer.

Int J Colorectal Dis

January 2025

Medical Oncology Department, National Cancer Institute, Cairo University, Giza, Egypt.

Purpose: The role of adjuvant chemotherapy in rectal cancer patients downstaged to ypT0-2 N0 after neoadjuvant chemoradiotherapy (CRT), and surgery is still debated. This study investigates the impact of adjuvant chemotherapy on survival outcomes in this patient population.

Methods: This retrospective study analyzed hospital records of rectal cancer cases from Shefa Al Orman Cancer Hospital between January 2016 and December 2020, focusing on patients downstaged to ypT0-2 N0 after neoadjuvant CRT and surgery.

View Article and Find Full Text PDF

The photo-induced CO-releasing properties of the dark-stable complex [RuCl(CO)L] (L = 2-(pyridin-2-yl)quinoxaline) were investigated under 468 nm light exposure in the presence and absence of biomolecules such as histidine, calf thymus DNA and hen egg white lysozyme. The CO release kinetics were consistent regardless of the presence of these biomolecules, suggesting that they did not influence the CO release mechanism. The quinoxaline ligand demonstrated exceptional cytotoxicity against human acute monocytic leukemia cells (THP-1), with evidence of potential DNA damage ascertained by comet assay, while it remained non-toxic to normal kidney epithelial cells derived from African green monkey (Vero) cell lines.

View Article and Find Full Text PDF

Studies aimed to evaluate the expected impact of alternative screening strategies are essential for optimizing colorectal cancer (CRC) screening offers, but such studies are lacking in Germany, where two screening colonoscopies (CS) 10 years apart are offered for men from age 50 and women from age 55. Our aim was to explore whether and to what extent the efficacy of utilizing two CS could be enhanced by alternative starting ages and screening intervals. We modeled the expected numbers of CRC cases, CRC deaths, years of potential life lost (YPLL), and disability-adjusted life years (DALYs) due to CRC in hypothetical cohorts of 100,000 men and women aged 45-85 using COSIMO, a validated Markov-based multi-state simulation model.

View Article and Find Full Text PDF

Cancer is a major health challenge globally and in Sri Lanka. Providing comprehensive information to patients is crucial for improving treatment outcomes and patient satisfaction, supported by evidence of its effectiveness in managing cancer pain. EORTC QLQ-INFO25, an information module developed by the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, is aimed at assessing cancer patients' perception of information received during different phases of care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!